🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a phase II Randomized comparison clinical trial of activated CIK ar...
Status
Withdrawn
Location
Institutional Review Board of Guangzhou Fuda Cancer Hospital
Start Date
2018-04-10
Trial ID
NCT03540199
Treatments Being Tested
The first testing of TargomiRs in the human setting: dose-finding studies i...
Status
Completed
Location
Concord Repatriation General Hospital
Start Date
2014-09
Trial ID
NCT02369198
Treatments Being Tested
Multiple myeloma is a cancer of the plasma cells in the bone marrow. The m...
Status
Recruiting
Location
Infirmary Health - Diagnostic & Medical Clinic (DMC)
Start Date
2026-01-14
Trial ID
NCT06980480
Treatments Being Tested
This phase I/II trial studies the side effects and best dose of ABBV-383 an...
Status
Not Yet Recruiting
Location
Mayo Clinic in Rochester
Start Date
2026-10-25
Trial ID
NCT07420959
This phase II trial tests whether mosunetuzumab and/or polatuzumab vedotin ...
Status
Recruiting
Location
Banner University Medical Center - Tucson
Start Date
2023-06-12
Trial ID
NCT05633615
The goal of this clinical trial is to compare the safety and efficacy (how ...
Status
Active Not Recruiting
Location
St. Joseph Heritage Healthcare
Start Date
2021-10-27
Trial ID
NCT05117242
Treatments Being Tested
In the present trial the chemotherapy- light treatment concept R-Pola-Glo w...
Status
Active Not Recruiting
Location
Uniklinik Innsbruck
Start Date
2023-03-20
Trial ID
NCT05798156
Treatments Being Tested
This Phase II, open-label, multicenter study will evaluate teclistamab in c...
Status
Not Yet Recruiting
Location
AUH
Start Date
2026-09-01
Trial ID
NCT07757412
Treatments Being Tested
The advent of immunotherapy has changed the treatment landscape for patient...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-04-21
Trial ID
NCT06946836
Treatments Being Tested
This is a phase II Randomized comparison clinical trial of activated CIK ar...
Status
Withdrawn
Location
Institutional Review Board of Guangzhou Fuda Cancer Hospital
Start Date
2019-05-20
Trial ID
NCT03524261
Treatments Being Tested